Format

Send to

Choose Destination
Clin Transl Sci. 2018 Jan;11(1):77-84. doi: 10.1111/cts.12495. Epub 2017 Sep 8.

The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences.

Author information

1
Center for Public Health Systems Science, George Warren Brown School of Social Work, Washington University in St. Louis, Missouri, USA.
2
Becker Medical Library, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
3
Institute of Clinical and Translational Sciences (ICTS), Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
4
Division of General Medical Sciences, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.

Abstract

We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in-house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center